Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion type Assertion NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_head.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion description "[BCL9 is required for efficient beta-catenin-mediated transcription in human cell lines whose Wnt pathway is active, including colorectal cancer cells, indicating its potential as a drug target in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_provenance.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion evidence source_evidence_literature NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_provenance.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion SIO_000772 18627596 NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_provenance.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion wasDerivedFrom befree-20140225 NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_provenance.
- NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_assertion wasGeneratedBy ECO_0000203 NP442009.RAE4PF_FGQNmLerx0eQljHBp4SNWgeIh42rHCv9OF8skc130_provenance.